Encompass Health Corporation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Encompass Health Corporation (EHC) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $17.40 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-05-11
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-03-31 was $17.40M.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was -$13.30M, a 134.10% decline year-over-year.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $39.00M, a 53.54% increase year-over-year.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was $25.40M.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was $26.10M, a 56.29% increase from fiscal 2018.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $16.70M, a 8.44% increase from fiscal 2017.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was $15.40M.
- Encompass Health Corporation cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2016 was -$6.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2020-03-31 | $17.40M 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $26.10M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $380.30M 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | $154.20M 10-Q · filed 2019-07-31 | |||
| 2019-03-31 | -$13.30M 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $16.70M 10-K · filed 2020-02-27 | |||
| 2018-09-30 | $4.20M 10-Q · filed 2019-10-31 | |||
| 2018-06-30 | $8.00M 10-Q · filed 2019-07-31 | |||
| 2018-03-31 | $39.00M 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $15.40M 10-K · filed 2020-02-27 | |||
| 2017-09-30 | $37.00M 10-Q · filed 2018-10-31 | |||
| 2017-06-30 | $42.70M 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $25.40M 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | -$6.10M 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |